432A — Cliniphar Balance Sheet
0.000.00%
Last trade - 00:00- ¥1bn
- ¥3bn
- ¥4bn
Annual balance sheet for Cliniphar, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 1,194 | 1,143 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 106 | 132 |
| Total Inventory | ||
| Total Other Current Assets | ||
| Total Current Assets | 1,552 | 1,627 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 17.5 | 32.9 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 2,280 | 2,662 |
| Accounts Payable | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 273 | 595 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 1,412 | 1,646 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Unrealized Gain / Loss | ||
| Other Equity | ||
| Total Equity | 868 | 1,016 |
| Total Liabilities & Shareholders' Equity | 2,280 | 2,662 |
| Total Common Shares Outstanding |